Bookmark
Forward
Targeting RNA Splicing Overcomes Leukemia Resistance to BCL2 Inhibition.
Cancer discovery 2023 Mar 01Sizes of these terms reflect their relevance to your search.
Inactivation of RNA splicing factors enhances BCL2 inhibition in acute myeloid leukemia (AML). ©2023 American Association for Cancer Research.
Citation
Targeting RNA Splicing Overcomes Leukemia Resistance to BCL2 Inhibition. Cancer discovery. 2023 Mar 01;13(3):OF3
Mesh Tags
Substances
PMID: 36607233
View Full Text
